Literature DB >> 31656773

Liquid biopsies in renal cell carcinoma with focus on epigenome analysis.

Alessia Cimadamore1, Matteo Santoni2, Francesco Massari3, Liang Cheng4, Antonio Lopez-Beltran5, Marina Scarpelli1, Rodolfo Montironi1.   

Abstract

Entities:  

Year:  2019        PMID： 31656773      PMCID： PMC6789363          DOI： 10.21037/atm.2019.07.30

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  26 in total

1.  Cell-Free SHOX2 DNA Methylation in Blood as a Molecular Staging Parameter for Risk Stratification in Renal Cell Carcinoma Patients: A Prospective Observational Cohort Study.

Authors:  Maria Jung; Jörg Ellinger; Heidrun Gevensleben; Isabella Syring; Christine Lüders; Luka de Vos; Svenja Pützer; Friedrich Bootz; Jennifer Landsberg; Glen Kristiansen; Dimo Dietrich
Journal:  Clin Chem       Date:  2019-01-09       Impact factor: 8.327

2.  Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.

Authors:  Kim E M van Kessel; Willemien Beukers; Irene Lurkin; Angelique Ziel-van der Made; Kirstin A van der Keur; Joost L Boormans; Lars Dyrskjøt; Mirari Márquez; Torben F Ørntoft; Francisco X Real; Ulrika Segersten; Núria Malats; Per-Uno Malmström; Wim Van Criekinge; Ellen C Zwarthoff
Journal:  J Urol       Date:  2016-10-13       Impact factor: 7.450

3.  Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.

Authors:  M R Morris; C J Ricketts; D Gentle; F McRonald; N Carli; H Khalili; M Brown; T Kishida; M Yao; R E Banks; N Clarke; F Latif; E R Maher
Journal:  Oncogene       Date:  2010-12-06       Impact factor: 9.867

Review 4.  Circulating nucleic acids (CNAs) and cancer--a survey.

Authors:  M Fleischhacker; B Schmidt
Journal:  Biochim Biophys Acta       Date:  2006-10-07

5.  A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients.

Authors:  Iris J H van Vlodrop; Sophie C Joosten; Tim De Meyer; Kim M Smits; Leander Van Neste; Veerle Melotte; Marcella M L L Baldewijns; Leo J Schouten; Piet A van den Brandt; Jana Jeschke; Joo Mi Yi; Kornel E Schuebel; Nita Ahuja; James G Herman; Maureen J Aarts; Fred T Bosman; Wim Van Criekinge; Manon van Engeland
Journal:  Clin Cancer Res       Date:  2016-10-18       Impact factor: 12.531

6.  Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.

Authors:  Alan W Partin; Leander Van Neste; Eric A Klein; Leonard S Marks; Jason R Gee; Dean A Troyer; Kimberly Rieger-Christ; J Stephen Jones; Cristina Magi-Galluzzi; Leslie A Mangold; Bruce J Trock; Raymond S Lance; Joseph W Bigley; Wim Van Criekinge; Jonathan I Epstein
Journal:  J Urol       Date:  2014-04-18       Impact factor: 7.450

7.  Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients.

Authors:  Hongbiao Lu; Jonas Busch; Monika Jung; Silke Rabenhorst; Bernhard Ralla; Ergin Kilic; Steffen Mergemeier; Nils Budach; Annika Fendler; Klaus Jung
Journal:  Clin Chim Acta       Date:  2015-11-10       Impact factor: 3.786

8.  Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients.

Authors:  Andrew Rhodes; Stephen J Wort; Helen Thomas; Paul Collinson; E David Bennett
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

9.  Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.

Authors:  Christopher J Ricketts; Victoria K Hill; W Marston Linehan
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

10.  A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma.

Authors:  Jin-Huan Wei; Ahmed Haddad; Kai-Jie Wu; Hong-Wei Zhao; Payal Kapur; Zhi-Ling Zhang; Liang-Yun Zhao; Zhen-Hua Chen; Yun-Yun Zhou; Jian-Cheng Zhou; Bin Wang; Yan-Hong Yu; Mu-Yan Cai; Dan Xie; Bing Liao; Cai-Xia Li; Pei-Xing Li; Zong-Ren Wang; Fang-Jian Zhou; Lei Shi; Qing-Zuo Liu; Zhen-Li Gao; Da-Lin He; Wei Chen; Jer-Tsong Hsieh; Quan-Zhen Li; Vitaly Margulis; Jun-Hang Luo
Journal:  Nat Commun       Date:  2015-10-30       Impact factor: 14.919
View more
  1 in total

1.  The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma.

Authors:  Guobin Tan; Zijun Xuan; Zhiqin Li; Shuitong Huang; Guangming Chen; Yonglu Wu; Xianxi Chen; Zhijin Liang; Aiming Wu
Journal:  Transl Androl Urol       Date:  2020-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.